logo
ProjectEnded

A novel bone implant with enhanced bone healing capacity

Ended · Sweden

Source: EU Funding & Tenders Portal

The objective of the project is to bring the first bone implant with enhanced bone healing capacity to the market and clinical practice. The market demand for bone implants is steadily increasing driven by aging populations, increased demand for high quality of life and an increasing number of joint reconstruction surgeries. Enhancement of the bone healing process is often necessary, especially fo

Status
Closed
Sector
Commercial
Location
Sweden
Updated
22 Jul 2026
Source
EU Funding & Tenders Portal

ConstructChat

Ask ConstructChat about A novel bone implant with enhanced bone healing capacity

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

3 Q
The project “A novel bone implant with enhanced bone healing capacity” is an infrastructure initiative in the Commercial sector, located in Sweden. Taiyo aggregates data on it from EU Funding & Tenders Portal.

Participants

Not available for this record.

Status

Original status

ended

Taiyo status

Closed

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

The objective of the project is to bring the first bone implant with enhanced bone healing capacity to the market and clinical practice. The market demand for bone implants is steadily increasing driven by aging populations, increased demand for high quality of life and an increasing number of joint reconstruction surgeries. Enhancement of the bone healing process is often necessary, especially for patients with larger bone voids and gaps. The existing clinical methods targeting this need are based on the combination of Bone Graft Substitutes (BGS) with: • systemic treatment with Bone Active Drug (BAD), or • the off-label use of the BAD. Both alternatives create risks for side-effects and complications. BONESUPPORT will move beyond the current state of the art and propose CERAMENT-BC – the first product combining a BGS with a BAD (bisphosphonate), enhancing the healing capacity of the implant. The commercial potential of this nano-modified material lies in the efficient local delivery of the drug to the targeted skeletal side, minimizing side-effects and improving quality of life for the patient. The targeted users are orthopedic surgeons who need new methods for the enhancement of the bone healing process, reduction of secondary fractures and postoperative complications. CERAMENT-BC will meet those needs by combining the advantages of BGS and BAD and thus providing both fracture stability and a local therapeutic effect. The Phase 1 study will develop a business plan for the commercialisation of the product. Assuring cost-efficient and innovative approaches to the treatment of musculoskeletal conditions is an EU-wide challenge. The project will address this challenge by proposing a new treatment option which for the first time combines an injectable biomaterial with a BAD.

Location

Country

Sweden

Source

Source

EU Funding & Tenders Portal

URL

More Details

Record type

Project

Sector

Commercial

Article published date

2026-01-15

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project